User profiles for E Kelly

Elizabeth J Kelly

- Verified email at astrazeneca.com - Cited by 14346

Erin L. Kelly

- Verified email at mit.edu - Cited by 13702

Eric E. Kelley

- Verified email at hsc.wvu.edu - Cited by 6985

The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors

…, A Christopoulos, AP Davenport, E Kelly… - British journal of …, 2019 - Wiley Online Library
The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial
publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 …

[HTML][HTML] History of oncolytic viruses: genesis to genetic engineering

E Kelly, SJ Russell - Molecular therapy, 2007 - cell.com
Since the turn of the nineteenth century, when their existence was first recognized, viruses
have attracted considerable interest as possible agents of tumor destruction. Early case …

Agonist‐selective mechanisms of GPCR desensitization

E Kelly, CP Bailey, G Henderson - British journal of …, 2008 - Wiley Online Library
The widely accepted model of G protein‐coupled receptor (GPCR) regulation describes a
system where the agonist‐activated receptors couple to G proteins to induce a cellular …

An aged immune system drives senescence and ageing of solid organs

…, SE Lewis, NF LaRusso, NV Vo, Y Wang, EE Kelley… - Nature, 2021 - nature.com
Ageing of the immune system, or immunosenescence, contributes to the morbidity and
mortality of the elderly 1 , 2 . To define the contribution of immune system ageing to organism …

[HTML][HTML] Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind …

…, B Hallis, MM Hou, D Jenkin, CCD Joe, EJ Kelly… - The Lancet, 2020 - thelancet.com
Background Older adults (aged ≥70 years) are at increased risk of severe disease and
death if they develop COVID-19 and are therefore a priority for immunisation should an …

[HTML][HTML] Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

…, HE Humphries, B Jepson, EJ Kelly, E Plested… - Nature medicine, 2021 - nature.com
The global supply of COVID-19 vaccines remains limited. An understanding of the immune
response that is predictive of protection could facilitate rapid licensure of new vaccines. Data …

[HTML][HTML] Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant

…, CK Wibmer, NM Durham, EJ Kelly… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

[HTML][HTML] Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19

…, R Beavon, K Dey, P Garbes, EJ Kelly… - … England Journal of …, 2022 - Mass Medical Soc
Background The monoclonal-antibody combination AZD7442 is composed of tixagevimab
and cilgavimab, two neutralizing antibodies against severe acute respiratory syndrome …

[HTML][HTML] Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine

…, MC Nason, JA Green, EJ Kelly… - … England Journal of …, 2021 - Mass Medical Soc
Background The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large,
diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (…

Best practices or best guesses? Assessing the efficacy of corporate affirmative action and diversity policies

A Kalev, F Dobbin, E Kelly - American sociological review, 2006 - journals.sagepub.com
Employers have experimented with three broad approaches to promoting diversity. Some
programs are designed to establish organizational responsibility for diversity, others to …